FPR1, as a Potential Biomarker of Diagnosis and Infliximab Therapy Responses for Crohn’s Disease, is Related to Disease Activity, Inflammation and Macrophage Polarization

Ye C, Zhu S, Yuan J, Yuan X

Journal of Inflammation Research 2024, 17:3949-3966

Published Date: 19 June 2024